When given as an intravenous bolus, immediate and full platelet inhibition of ADP-induced platelet aggregation was observed. The clinical efficacy and safety of elinogrel will be further evaluated ...

IPA: Inhibition of platelet aggregation; iv.: Intravenous. The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or ...

However, platelet reactivity to clopidogrel is variable and stent thrombosis can occur suddenly and unexpectedly in up to 3% of patients. Is responsiveness to clopidogrel an indicator of risk of ...

Current thrombotic platelet inhibitors used clinically often lead to bleeding side effects since they inhibit both processes. The next steps would involve testing these pathways in genetically ...

Current thrombotic platelet inhibitors used clinically often lead to bleeding side effects since they inhibit both processes. The next steps would involve testing these pathways in genetically ...